Clinical Trials on Swallowing, Air

Total 1009 results

Eli Lilly and Company
Incyte Corporation

Active, not recruiting

A Study of Baricitinib (LY3009104) in Participants With Severe or Very Severe Alopecia Areata (BRAVE-AA1)

Alopecia Areata

United States, Japan, Puerto Rico, Mexico, Korea, Republic of
Eurofarma Laboratorios S.A.

Active, not recruiting

Treatment of Androgenetic Alopecia in Men for 24 Weeks (MINOX)

Alopecia

Brazil
Q32 Bio Inc.
Innovaderm Research Inc.

Active, not recruiting

Randomized, Double-Blind, Placebo-Controlled Phase 2a, Proof-of-Concept Trial of ADX-914 Phase 2a Trial for the Treatment of Severe Alopecia Areata (SIGNAL-AA)

Alopecia Areata

United States
Concert Pharmaceuticals

Completed

A Study to Evaluate the Durability of Response Study of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Ornovi, Inc.

Withdrawn

A First in Human Single and Multiple Ascending Dose and Open Label Food Effect Study of OR-101 in Healthy Subjects

Alopecia Areata

Australia
Egymedicalpedia

Completed

Evaluation of the Effect of Topical Calcipotriol Versus Platelet-Rich Plasma

Alopecia Areata

Egypt
Pfizer
Arena is a wholly owned subsidiary of Pfizer

Completed

Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata

Alopecia Areata

United States, Canada
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) (THRIVE-AA2)

Alopecia Areata

Spain, United States, Poland, Canada, France, Germany, Hungary
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) (THRIVE-AA1)

Alopecia Areata

United States, Canada, Poland, France, Spain
Yale University

Completed

Follicular Revival in Treatment-resistant Alopecia Areata: Evaluating Use of Micro-needling

Alopecia Areata

United States
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata

Alopecia Areata

China
Bioithas SL
Bionou Research, S.L.

Completed

Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata

Alopecia Areata

Spain
Centre Hospitalier Universitaire de Nice

Terminated

Evaluation of the Efficacy and Tolerability of Treatment With Interleukin-2 in Severe and Resistant Alopecia Areata (IL2)

Alopecia Areata

France
Tufts Medical Center
Pfizer

Withdrawn

Topical Crisaborole in Patients With Alopecia Areata

Alopecia Areata

United States
Icahn School of Medicine at Mount Sinai
Novartis

Terminated

A Study of Secukinumab for the Treatment of Alopecia Areata

Alopecia Areata

United States
University of Minnesota

Completed

Combined Restylane and Triamcinolone Acetonide Injections for the Treatment of Alopecia Areata

Alopecia Areata

United States
Legacy Healthcare SA

Completed

Efficacy, Safety and Tolerability of CG428 Cutaneous Solution on Chemotherapy Induced Alopecia; Controlled Study (ELAN) (ELAN)

Alopecia

Switzerland
Columbia University
University of Minnesota

Terminated

Intralesional Steroids in the Treatment of Alopecia Areata

Alopecia Areata

United States
Columbia University
Locks of Love

Completed

Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis

Alopecia Areata

United States
Allergan

Completed

A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males

Alopecia

United States
Aswan University Hospital

Completed

Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata

Alopecia Areata

Egypt
University of Florida

Completed

Point-of-Care Adipose-derived Cells for Hair Growth (ASVF-2016)

Androgenetic Alopecia

United States
GlaxoSmithKline

Completed

A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia

Alopecia
Apifix

Terminated

Safety and Effectiveness Evaluation of the Minimal Invasive Deformity Correction (MID-C) System in Adolescent Idiopathic Scoliosis (AIS) (MID-C)

Adolescent Idiopathic Scoliosis (AIS)

France
Apifix

Completed

Feasibility Study of MID-C for AIS (MID-C)

Adolescent Idiopathic Scoliosis (AIS)

Hungary, Romania
Postgraduate Institute of Medical Education and...

Completed

Comparison of Topical Latanoprost vs Topical Corticosteroid in Treatment of Localized Alopecia Areata (COLA)

Alopecia Areata

India
University of British Columbia

Unknown

Excimer Light for Alopecia Areata

Alopecia Areata

Canada
University of British Columbia

Completed

The Efficacy and Safety of Different Concentrations of Localized Injections of Steroids in the Treatment of Alopecia Areata

Alopecia Areata

Canada
Columbia University

Withdrawn

A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata

Alopecia Areata

United States
University of California, San Francisco

Completed

Efficacy Study of Latanoprost and Bimatoprost Solutions in Promoting Eyelash Growth in Patients With Alopecia Areata

Alopecia Areata

United States
Hamamatsu University

Unknown

The Effect of 0.5% Roxithromycin Lotion for Androgenetic Alopecia

Alopecia

Japan
Sheba Medical Center

Unknown

Comparative Study Examining the Effectiveness in Use of a DERMOJET and a Normal Syringe Treatment for Patients With Hair Loss - Alopecia Areata

Alopecia Areata

Israel
Hordinsky, Maria K., MD
3M; National Alopecia Areata Foundation

Completed

Aldara for the Treatment of Extensive Alopecia Areata

Alopecia Areata

United States
Sanofi

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

Alopecia Areata
Assiut University

Not yet recruiting

Topical Simvastatin Versus Topical Steroid in Treatment of Alopecia Areata

Alopecia Areata

Egypt
Zagazig University

Recruiting

Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata

Alopecia Areata

Egypt
NEXTGEN Bioscience

Not yet recruiting

Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia Areata

Alopecia Areata
Al-Azhar University

Not yet recruiting

Methotrexate Versus Triamcinilone Acetonide in Treatment of Recalcitrant Alopecia Areata

Alopecia Areata

Egypt
AbbVie

Recruiting

A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata (Up-AA)

Alopecia Areata

United States, Australia, Japan, Puerto Rico, New Zealand, China, Canada, Brazil, United Kingdom, Korea, Republic of, Chile
Sohag University

Recruiting

Polymorphism of Janus Kinase 1 and 2 (JAK 1&2) in Patients With Alopecia Areata

Alopecia Areata

Egypt
Sohag University

Not yet recruiting

Efficacy of Combined Microneedling With Methotrexate in Treatment of Alopecia Areata

Alopecia Areata

Egypt
Montefiore Medical Center
Paxman

Recruiting

Scalp Cooling for Chemotherapy-Induced Alopecia in Patients of Color

Alopecia

United States
Institute of Biophysics and Cell Engineering of...
Belarusian State Medical University

Not yet recruiting

Treatment of Alopecia Using Follicular Stem Cells

Alopecia
Al-Azhar University

Recruiting

Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata (AA)

Alopecia Areata

Egypt
Tel-Aviv Sourasky Medical Center

Not yet recruiting

Fecal Transplant for Alopecia Areata

Alopecia Areata
Alexandria University

Not yet recruiting

Intralesional Vitamin D in Alopecia Areata

Alopecia Areata

Egypt
Suzhou Koshine Biomedica, Inc.

Completed

To Evaluate Safety and Efficacy of KX-826 in Chinese Female Subjects With Androgenetic Alopecia

Alopecia

China
Eli Lilly and Company
Incyte Corporation

Active, not recruiting

A Study of Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata (BRAVE-AA2)

Alopecia Areata

Israel, China, United States, Puerto Rico, Korea, Republic of, Taiwan, Australia, Japan, Brazil, Argentina
Dr. Peter C. Friedman

Completed

Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss

Androgenetic Alopecia

United States
CorEvitas

Enrolling by invitation

CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Alopecia Areata

United States

3

Subscribe